International Journal of Scientific Research in Science Engineering and Technology, Journal Year: 2024, Volume and Issue: unknown, P. 87 - 101
Published: Jan. 1, 2024
This ground-breaking research delves into the potential of novel triazolopyrimidine derivatives as inhibitors SARS-CoV, employing a robust in-silico approach that integrates molecular docking studies, dynamics simulations, and comprehensive ADMET parameter assessments. The overarching goal is to identify compounds exhibit both binding affinity favourable pharmacokinetic profiles, laying foundation for antiviral drug development. methodology begins with meticulous selection triazolo pyrimidine based on their structural characteristics. Molecular studies are then conducted, focusing specific site SARS-CoV target. Subsequent simulations provide dynamic perspective stability interactions over time. assessments employed evaluate drug-likeness safety, crucial factors in determining compounds' viability candidates. findings this underscore promising between targeted viral site, suggesting SARS-CoV. Importantly, contribute valuable insights properties compounds, informing overall safety suitability further Notably, include comparative analysis standard remdesivir, revealing energy scores surpassing those remdesivir. finding signifies advantage terms effectiveness against implications profound, extending beyond identification contributing essential knowledge development therapeutics coronaviruses general. study serves stepping stone subsequent experimental validation optimization identified propelling future discovery endeavours fight coronaviral infections.
Language: Английский